Those involving the pancreatic head/uncinate that require skeletonizing the root of the mesentery (SMA ... Of note, IRE is being applied to two patient populations: those deemed unresectable, who ...

If it’s unresectable, you need therapy that goes ... surgery can depend on where the cancer is. If it’s at the head of the ...

Chemoradiation is considered a reasonable treatment option for patients with locally advanced, unresectable pancreatic cancer. The chemotherapy agents 5-fluorouracil, gemcitabine, capecitabine and ...

Disparities in outcomes of pancreatic cancer hospitalizations: A ten-year trend study. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does not ...

Historically, high-dose radiation has been considered beneficial for improving survival rates in patients with unresectable pancreatic cancer. Yet, the application has often been limited due to ...

The San Francisco biotech confirmed that neither the PanCAN Precision Promise study in metastatic pancreatic cancer nor the LAPIS trial in patients with locally advanced, unresectable pancreatic ...

Approximately 30% of pancreatic cancer patients present with locally unresectable disease with no evidence of distant metastases. Local control in this patient population can provide effective ...

NBTXR3 is under evaluation for multiple solid tumors, with FDA Fast Track designation for head and neck squamous cell carcinoma. The first participant has been dosed on the phase 2 CONVERGE study ...

High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring ... combination trial of Alpha DaRT with a checkpoint inhibitor ...

High disease control rate and strong interim safety results observed in pancreatic cancer patients ... for recurrent unresectable or metastatic head and neck squamous cell carcinoma (HNSCC ...